News stories about Marchex (NASDAQ:MCHX) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Marchex earned a coverage optimism score of 0.07 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 46.797972722452 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
A number of analysts recently commented on the company. Zacks Investment Research cut Marchex from a “hold” rating to a “sell” rating in a research report on Thursday, May 10th. TheStreet cut Marchex from a “c-” rating to a “d+” rating in a research report on Wednesday, March 14th.
Marchex traded up $0.14, reaching $2.76, during mid-day trading on Wednesday, MarketBeat reports. 45,820 shares of the stock traded hands, compared to its average volume of 88,207. The stock has a market cap of $115.09 million, a PE ratio of -19.71 and a beta of 1.26. Marchex has a 12-month low of $2.55 and a 12-month high of $3.67.
Marchex (NASDAQ:MCHX) last posted its quarterly earnings data on Thursday, May 3rd. The technology company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). The firm had revenue of $21.90 million for the quarter, compared to analysts’ expectations of $21.10 million. Marchex had a negative net margin of 3.99% and a negative return on equity of 3.54%. equities research analysts anticipate that Marchex will post -0.09 EPS for the current fiscal year.
In related news, major shareholder Edenbrook Capital, Llc purchased 59,358 shares of the business’s stock in a transaction on Wednesday, February 28th. The stock was acquired at an average price of $3.20 per share, with a total value of $189,945.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders have purchased 262,684 shares of company stock valued at $755,656. 27.35% of the stock is owned by company insiders.
Marchex, Inc operates as a call analytics company. Its products include Marchex Call Analytics, an analytics technology platform that provides data and insights to measure the performance of mobile, online, and offline advertising for advertisers and small business resellers; and Marchex Speech Analytics delivers actionable operational and advertising insights of inbound calls from consumer's interactions.
Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.